RFA
ATRS

Reilly Financial Advisors’s Antares Pharma, Inc. ATRS Stock Holding History

Reilly Financial Advisors’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$4K Buy
+1,000
New +$3.5K ﹤0.01% 913
2021
Q3 		– Sell
-1,000
Closed -$4K – 1102
2021
Q2 		$4K Hold
1,000
– – ﹤0.01% 845
2021
Q1 		$4K Buy
+1,000
New +$4.33K ﹤0.01% 840

Other funds holding ATRS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FWSM
First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Amundi
Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Reilly Financial Advisors's ATRS Position: Q4 2021 in Review

Reilly Financial Advisors opened a new position in Antares Pharma, Inc. (ATRS) in Q4 2021: 1,000 shares worth $4K. The stake represents ﹤0.01% of the portfolio and ranks #913 among its holdings. This is a return to the name: Reilly Financial Advisors previously reported a position in ATRS as recently as Q2 2021.

Reilly Financial Advisors first reported a position in ATRS in Q1 2021 and has held it in 3 quarters since. 162 funds tracked by Wall St. Rank hold ATRS as of Q4 2021.

  • Reilly Financial Advisors held 1,000 shares of Antares Pharma, Inc. worth $4K as of Q4 2021.
  • Antares Pharma, Inc. was a new Reilly Financial Advisors position in Q4 2021.
  • Antares Pharma, Inc. made up ﹤0.01% of Reilly Financial Advisors's portfolio in Q4 2021, its #913 holding.
  • Reilly Financial Advisors first reported a position in Antares Pharma, Inc. in Q1 2021 and has held it in 3 quarters since.
  • 162 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q4 2021.

Based on Reilly Financial Advisors's 13F filing for Q4 2021, filed 25 Jan 2022.